Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04756765
Title Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stanford University
Indications

Her2-receptor negative breast cancer

Therapies

Talazoparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.